D. E. Shaw & Co., Inc. Zoetis Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $1.72 Million - $2.11 Million	11,800 New	11,800 $2.05 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $2.88 Million - $3.39 Million	-20,000 Reduced 66.67%	10,000 $1.58 Million
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $1.12 Million - $1.43 Million	10,000 Added 50.0%	30,000 $4.11 Million
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $926,600 - $1.45 Million	10,000 Added 100.0%	20,000 $2.35 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $810,504 - $924,696	7,200 Added 257.14%	10,000 $1.25 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $71,910 - $80,280	-900 Reduced 24.32%	2,800 $239,000
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $264,587 - $313,353	3,700 New	3,700 $309,000

1,897

423M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.